Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy
Most Cited Paper
in Epilepsy research and treatment
18 Months Post-Publication
Class of 2026
“Multi‐omics technologies and molecular biomarkers in brain tumor‐related epilepsy”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/epilepsy-research-and-treatment/2026/
Topics
Brain tumor-related epilepsy (BTRE) · Multi-omics technologies · Genomics · Transcriptomics · Epigenomics · Proteomics · Metabolomics · BRAF V600E variant · IDH variants · D2HG overproduction · FOXO4 · VLGR1 · miR-128 · miRNA-196b · lncRNA UBE2R2-AS1 · Protein acetylation · AQP4 · BCL2A1 · Ki-67 · PI3K/AKT/mTOR pathway
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Epilepsy research and treatment Papers, Class of 2026. https://pri.pepkio.com/top-papers/epilepsy-research-and-treatment/2026. Accessed 2026-07-13. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459